ALEXION PHARMACEUTICALS, INC. Insider Trading for December 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for December 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 22.90 | 16,680 | 381,972 | 400,000 | |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 182.03 | 13,735 | 2,500,182 | 929,941 | 943.7 K to 929.9 K (-1.46 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 178.41 | 1,600 | 285,456 | 943,676 | 945.3 K to 943.7 K (-0.17 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 177.81 | 11,395 | 2,026,145 | 945,276 | 956.7 K to 945.3 K (-1.19 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 177.67 | 3,685 | 654,714 | 956,671 | 960.4 K to 956.7 K (-0.38 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 22.90 | 16,680 | 381,972 | 960,356 | 943.7 K to 960.4 K (+1.77 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 182.08 | 5,493 | 1,000,165 | 157,277 | 162.8 K to 157.3 K (-3.37 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 182.03 | 5,494 | 1,000,073 | 113,122 | 118.6 K to 113.1 K (-4.63 %) |
Dec 16 2014 | ALXN | ALEXION PHARMACEUT ... | Brennan David R | Director | Buy | P | 186.99 | 500 | 93,495 | 1,268 | 768 to 1.3 K (+65.10 %) |
Dec 15 2014 | ALXN | ALEXION PHARMACEUT ... | Veneman Ann M | Director | Sell | S | 193.03 | 1,235 | 238,392 | 3,447 | 4.7 K to 3.4 K (-26.38 %) |
Dec 15 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 195.53 | 3,570 | 698,042 | 20,962 | 24.5 K to 21 K (-14.55 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 22.90 | 16,665 | 381,629 | 416,680 | |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 22.90 | 46,655 | 1,068,400 | 433,345 | |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.98 | 13,279 | 238,756 | 0 | |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.98 | 56,721 | 1,019,844 | 13,279 | |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 199.94 | 16,665 | 3,332,000 | 943,676 | 960.3 K to 943.7 K (-1.74 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 22.90 | 16,665 | 381,629 | 960,341 | 943.7 K to 960.3 K (+1.77 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 200.39 | 6,903 | 1,383,292 | 943,676 | 950.6 K to 943.7 K (-0.73 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 199.80 | 24,497 | 4,894,501 | 950,579 | 975.1 K to 950.6 K (-2.51 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 198.19 | 9,627 | 1,907,975 | 975,076 | 984.7 K to 975.1 K (-0.98 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 197.72 | 14,223 | 2,812,172 | 984,703 | 998.9 K to 984.7 K (-1.42 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 196.73 | 4,684 | 921,483 | 998,926 | 1 M to 998.9 K (-0.47 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 22.90 | 46,655 | 1,068,400 | 1,003,610 | 957 K to 1 M (+4.88 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.98 | 13,279 | 238,756 | 956,955 | 943.7 K to 957 K (+1.41 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 198.81 | 900 | 178,929 | 943,676 | 944.6 K to 943.7 K (-0.10 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 198.06 | 14,194 | 2,811,264 | 944,576 | 958.8 K to 944.6 K (-1.48 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 197.26 | 21,396 | 4,220,575 | 958,770 | 980.2 K to 958.8 K (-2.18 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 196.25 | 20,231 | 3,970,334 | 980,166 | 1 M to 980.2 K (-2.02 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.98 | 56,721 | 1,019,844 | 1,000,397 | 943.7 K to 1 M (+6.01 %) |
Dec 08 2014 | ALXN | ALEXION PHARMACEUT ... | BURNS M MICHELE | Director | Buy | P | 167.32 | 10 | 1,673 | 788 | 778 to 788 (+1.29 %) |
Dec 08 2014 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | SVP, Chief HR Offic ... | Option Exercise | M | 57.02 | 10,000 | 570,200 | 14,375 | |
Dec 08 2014 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | SVP, Chief HR Offic ... | Sell | S | 196.25 | 10,000 | 1,962,500 | 16,272 | 26.3 K to 16.3 K (-38.06 %) |
Dec 08 2014 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | SVP, Chief HR Offic ... | Buy | M | 57.02 | 10,000 | 570,200 | 26,272 | 16.3 K to 26.3 K (+61.46 %) |
Dec 08 2014 | ALXN | ALEXION PHARMACEUT ... | KELLER WILLIAM R | Director | Sell | S | 196.25 | 5,000 | 981,250 | 7,276 | 12.3 K to 7.3 K (-40.73 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 20.90 | 20,000 | 418,000 | 100,000 | |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 30,000 | 539,400 | 1,832 | |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 25,000 | 449,500 | 31,832 | |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 202.76 | 200 | 40,552 | 162,770 | 163 K to 162.8 K (-0.12 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 201.79 | 11,358 | 2,291,931 | 162,970 | 174.3 K to 163 K (-6.52 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 200.82 | 5,782 | 1,161,141 | 174,328 | 180.1 K to 174.3 K (-3.21 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 199.53 | 3,447 | 687,780 | 180,110 | 183.6 K to 180.1 K (-1.88 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 198.28 | 3,468 | 687,635 | 183,557 | 187 K to 183.6 K (-1.85 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 197.45 | 3,438 | 678,833 | 187,025 | 190.5 K to 187 K (-1.81 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 196.46 | 9,037 | 1,775,409 | 190,463 | 199.5 K to 190.5 K (-4.53 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 195.55 | 13,270 | 2,594,949 | 199,500 | 212.8 K to 199.5 K (-6.24 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 20.90 | 20,000 | 418,000 | 212,770 | 192.8 K to 212.8 K (+10.38 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.98 | 30,000 | 539,400 | 192,770 | 162.8 K to 192.8 K (+18.43 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 200.16 | 25,000 | 5,004,000 | 162,770 | 187.8 K to 162.8 K (-13.31 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.98 | 25,000 | 449,500 | 187,770 | 162.8 K to 187.8 K (+15.36 %) |